Global Markets and Technologies for Advanced Drug Delivery Systems – Yahoo Finance
Report Scope: This report aims to provide a comprehensive study of the global market for advance drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions regarding drug deliveries.
New York, Aug. 29, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Markets and Technologies for Advanced Drug Delivery Systems” – https://www.reportlinker.com/p01940407/?utm_source=GNW
An in-depth analysis of the global ADDS market includes historical data and market projections on sales by product type, application, route of administration, drug mechanism and region.The analysis describes the different types of ADDS products (immediate drug release technology, modified drug release, advanced extended release drug delivery devices, and advanced delayed release and pulsatile release drug delivery systems) and their current and historical market revenues.
This report also examines applications of ADDS (oncology, respiratory, inflammation and allergies, cardiovascular, ophthalmic, central nervous systems, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal, dermatology and other therapeutics). This ADDS report also covers the route of administration of a drug delivery system as well as the source of a carrier mechanism for drug delivery.
The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.
Report Includes:
– 61 data tables and 61 additional tables
– An up-to-date review and comprehensive analysis of the global markets for advanced drug delivery systems (ADDS) and processes
– Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current state of the advanced drug delivery market, recent technologies and platforms, and market participants
– Estimation of the actual market size and market forecast for advanced drug delivery systems in value terms, and their corresponding market share analysis by technology, application, route of administration, vehicle/carrier of drugs mechanism, and geographic region
– Assessment of major growth drivers, opportunities and challenges in this innovation driven market, with an update on the COVID-19 impact on advanced drug delivery systems
– Review of patents and patent applications filed on drug delivery release mechanisms, clinical trial landscape, and emerging developments in the global market
– Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
– Descriptive company profiles of the advanced drug-device combination products manufacturers, including 3M Co., Abbott Laboratories, B. Braun Melsungen AG, BD, Boston Scientific Corp., Medtronic, Sanofi S.A., and Terumo Corp.
Summary:
Drug delivery refers to technologies, formulations based on drug vehicles or carriers, and approaches (routes of administration) used to deliver drugs for various applications or therapeutic use.
Advanced drug delivery systems (ADDS) refer to the technologies used to control the drug release rate. The technology used dramatically depends on the kind of disease, type of drug and desired effect.
Advanced formulations and the use of novel drug vehicles have proven to increase the efficiency and efficacy of drug delivery systems, resulting in better treatment outcomes. Moreover, ADDS have become the holy grail in the treatment of several diseases and in unlocking the potential and value of pharma’s existing compounds, as well as in exploring the possibility of several new combinations, including ones that don’t make it to market due to their limitations or issues related to factors such as adsorption, solubility, toxicity, molecular weight, metabolism, distribution, and excretion.
Although the quest for advanced drug delivery systems and formulations began long ago, ADDS have gained more momentum in the past few decades with the development and advancement of formulations and technologies such as modified-release technologies, targeted-release technologies, and formulations based on nanoparticles, microparticles, polymer conjugates, interfering RNA (siRNA), monoclonal antibodies, intelligent/smart polymers, osmotically modulated drug delivery, liposomes and dendrimers.
The global ADDS market was valued at $REDACTED in 2021 and is expected to reach $REDACTED by 2027 at a CAGR of REDACTED%.The market is not likely to saturate any time soon.
Still, it should be boosted by patent expiries, targeted drug delivery systems, cell therapy, nanotechnology and biologics, which are expected to open up new opportunities for this market. The COVID-19 pandemic is also fueling R&D and the ADDS market overall.
Advanced drug delivery is an attractive industry with multifaceted growth opportunities in research and development, technologies, applications and formulations.
Market analysis based on drug release mechanism shows that controlled-released drug delivery and targeted-release drug delivery formulations command the largest market share, which is anticipated to remain the same over the next five years.Market analysis by route of administration suggests that oral route administration and oral dosage forms dominate the market.
The injectable sector is also expanding. To stay competitive, product differentiation is critical and demands high priority.
Oncology is the largest application area in the advanced drug delivery market due to the increasing use of new drug carriers and materials in targeted-release and controlled-release drug delivery, leading to better drug formulations meeting unmet market needs. The COVID-19 pandemic is also fueling new developments in the respiratory sector.
North America leads the global advanced drug delivery market, followed by Europe. The North American market is also expected to witness the highest growth (REDACTED) over the next five years.
Read the full report: https://www.reportlinker.com/p01940407/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Uranium is blowing higher Monday. All the miners are up: Cameco Corp , Uranium Energy Corp. , and Denison Mines . But we could see more upside here. DNN was over $2.00 at one point in 2021, and it appears the European push to keep Nuclear power going could be a nice catalyst for these names.
Jeff Bezos tweeted that he still loves McDonald’s 40 years after working the morning shift. He’s said this first job taught him responsibility.
Moscow is raking in more revenue than ever with the help of new buyers, new traders and the world’s seemingly insatiable demand for crude. “Nobody’s brave enough to embargo 7.5 million barrels a day of Russian oil and oil products.”
HELP MY CAREER For much of my 35 or so years in the workforce, I’ve prided myself on going the extra mile — such as trying to put in a solid 8-hour day that has sometimes stretched into a 10- to 12-hour day.
Shares of Apple topped around $175 in the middle of August and turned lower – we hope traders took appropriate action. The trading volume does not appear to have increased on the late August decline but the On-Balance-Volume (OBV) line is pointing lower. In this weekly Japanese candlestick chart of AAPL, below, we can see a top reversal pattern in August looking at the candles.
(Bloomberg) — Few outside of India had heard of Gautam Adani just a few years ago. Now the Indian businessman, a college dropout who first tried his luck as a diamond trader before turning to coal, has become the world’s third-richest person. Most Read from BloombergDOJ Response Raises Doubts on Trump ‘Special Master’ RequestFed’s QT to Hit ‘Full Stride’ With Central Bank Shrinking $9 Trillion PortfolioPowell Heaps Pressure on Risk Sentiment as More Catalysts Loom‘Inflation Fever’ Is Finally Br
Recent studies reveal how much money Americans have saved in their 401(k)s and other retirement plans, but the averages can be deceiving.
Yahoo Finance Live anchors discuss Amazon’s Jeff Bezos sharing via Twitter that his first job was at McDonald’s.
(Bloomberg) — An endemic shortage of chips costing anywhere from 50 cents to $10 is slowing down swathes of the $600 billion semiconductor industry, Taiwan Semiconductor Manufacturing Co.’s top executive warned Tuesday.Most Read from BloombergDOJ Response Raises Doubts on Trump ‘Special Master’ RequestFed’s QT to Hit ‘Full Stride’ With Central Bank Shrinking $9 Trillion PortfolioPowell Heaps Pressure on Risk Sentiment as More Catalysts Loom‘Inflation Fever’ Is Finally Breaking — But Central Ban
Tesla's CEO has been sounding the alarm on the importance of the Russian war in Ukraine for the world.
MELBOURNE (Reuters) -Woodside Energy Group Ltd more than tripled its interim dividend payout on Tuesday after the Australian gas producer posted a five-fold increase in first-half profit on booming oil and gas prices and its takeover of BHP Group's petroleum arm. Woodside has benefited from soaring liquefied natural gas (LNG) prices as sanctions on Russia after its invasion of Ukraine have forced gas buyers from Asia and Europe to seek alternative suppliers in what was already a tight market. "We're in uncharted waters," Chief Executive Meg O'Neill told Reuters, pointing to the Platts JKM benchmark price assessment rocketing to $71 per million British thermal units and the Dutch TTF gas hub price last week hitting roughly the equivalent of an oil price of $600 a barrel.
Is Pfizer stock a sell on an expected decline for Covid vaccine sales in the third quarter? Is PFE stock now a sell?
Blood thinners produced by drug giants Bristol Myers and Bayer fell short of predictions, leading shares of both stocks down Monday.
Retired Americans are feeling the pressure of returning to work due to rising prices and the COVID-19 pandemic. But reentering the workforce while earning Social Security benefits could have consequences. We'll take a look at the obstacles retirement-age Americans are … Continue reading → The post Unretiring? Don't Make These 3 Social Security Mistakes appeared first on SmartAsset Blog.
Depending on your age, if your income is below a certain threshold, you may not have to pay taxes. Here's what you need to know.
Yahoo Finance anchors discuss the launch of a Jio grocery platform in conjunction with WhatsApp.
Three steel stocks have formed valid bases and are in or near buy zones. However, views conflict on the steel market.
Barron's Retirement's second-annual top 10 list includes stories on managing financial anxiety, staying active during your senior years, three considerations for 401(k) millionaires contemplating early retirement, and more.
A California owner of a Tesla Model 3 sued the electric vehicle maker in a proposed class action over cars suddenly stopping for non-existent obstacles, calling it a "frightening and dangerous nightmare," according to the lawsuit. Tesla has rushed its autonomous driving cars to market with unsafe technology, including its driver assistant system which the company calls Autopilot or Full Self-Driving, and its emergency braking system, according to the lawsuit by Jose Alvarez Toledo of San Francisco. This adds to growing public and regulatory scrutiny of Tesla's driver assistant technology, despite Tesla CEO Elon Musk promising full self-driving by this year-end.
Blue Apron CEO Linda Findley joins Yahoo Finance Live to discuss the meal kit company's 10 year anniversary, competition, and growth in the at-home food space.